Physician

Joshua P June, DO

According to 2025 Medicare claims, Joshua June, DO (NPI: 1205147873) practices rheumatology in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is JOSHUA P JUNE DO (NPI: 1548717580; TIN: 813717934) and primary practice location at 48911-4285. June is affiliated with the POM ACO (ACO ID: A1297) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

June's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 746 traditional Medicare patients, billed 123,043 HCPCS/CPT codes, and received $1,668,368 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,058 prescription claims across 683 beneficiaries totaling $3,157,634 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2020 DME data shows 33 claims. Open Payments data shows 211 records totaling $569,156. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $173,265 to $1,668,368. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	168	4,185	$173,265
2016	542	31,357	$1,195,608
2017	1,344	93,563	$3,269,486
2018	1,378	137,442	$4,333,319
2019	1,394	157,398	$4,500,397
2020	1,050	142,532	$3,576,215
2021	1,284	142,823	$3,020,733
2022	1,047	109,640	$1,986,099
2023	848	110,111	$1,716,896
2024	746	123,043	$1,668,368

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	315	2,932	$984,979
2016	489	4,122	$2,587,618
2017	740	6,544	$5,008,191
2018	865	6,802	$5,566,248
2019	734	5,847	$4,722,481
2020	746	5,337	$5,424,644
2021	772	4,914	$3,941,224
2022	676	4,726	$3,177,585
2023	591	3,873	$3,181,456
2024	683	4,058	$3,157,634

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	48	$5,201
2018	N/R	36	$2,971
2019	N/R	48	$3,571
2020	N/R	33	$1,446
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	507	978	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	266	456	$60
J0897	Injection, denosumab, 1 mg	139	10,800	$20
96372	Injection of drug or substance under skin or into muscle	216	473	$9
36415	Insertion of needle into vein for collection of blood sample	96	140	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	49	1,372	$557,080
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	17	357	$485,436
Humira Pen	Adalimumab	34	1,120	$284,188
Enbrel Sureclick	Etanercept	29	812	$212,276
Rinvoq	Upadacitinib	28	840	$173,344

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	190	$14,375	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	21	$554,781	Amgen Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joshua P. June, DO?

Tedicare shows public-source Medicare data for Joshua P. June, DO (NPI 1205147873), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua P. June, DO have ACO affiliation data?

Joshua P. June, DO is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Joshua P. June, DO?

Joshua P. June, DO is linked to JOSHUA P JUNE DO (billing NPI 1548717580) in the available physician profile data.

Does Joshua P. June, DO have Open Payments data?

Joshua P. June, DO has 211 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.